C12R 2001/63
Vibrio
C12R2001/63 (Vibrio) appears on 30 US grants and 43 published applications in this corpus.
Search patents in C12R- Granted patents
- 30
- Published applications
- 43
- Assignees
- 49
- Inventors
- 149
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 3 |
| 2020 | 0 | 3 |
| 2021 | 2 | 3 |
| 2022 | 4 | 5 |
| 2023 | 1 | 1 |
| 2024 | 1 | 7 |
| 2025 | 3 | 9 |
| 2026 | 0 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Expression system for product manufacturing14 Oct 2025US 12,442,006 B2Novel Biotechnology USA, Inc.
- Use of enzyme that cleaves both alpha- and beta- 1,4-glycosidic bonds9 Sep 2025US 12,410,419 B2Korea University Research and Business Foundation
- Depolymerization of a polyhydroxyalkanoate and recycling of hydroxyalkonoate monomer obtained thereby via a metabolic process13 May 2025US 12,297,328 B2Kimberly-Clark Worldwide, Inc.
- Copper chelation therapeutics19 Nov 2024US 12,144,833 B1
- Methods of cloning nucleic acids or producing proteins in a low endotoxin organism5 Sep 2023US 11,746,321 B2Telesis Bio Inc.
- Oral vaccine20 Aug 2026US 2026/0240985 A1WestfäLische Wilhelms-UniversitäT MüNster
- Compositions and methods for detecting gastrointestinal pathogens30 Jul 2026US 2026/0218268 A1Gen-Probe Incorporated
- Chimeric genome organisms and methods synthesizing thereof4 Jun 2026US 2026/0152735 A1California Institute of Technology
- Cell-free protein synthesis systems, reaction mixtures for same, and methods for preparing proteins4 Jun 2026US 2026/0152778 A1Sanofi Pasteur Limited
- Compositions and particles for payload delivery30 Apr 2026US 2026/0116928 A1Thornhill Therapeutics, Inc.
Most cited
By later US patents
- Vibrio cholerae strain CVD103Hg.sup.r, method of making same, and vaccines derived therefrom35US 5,399,494 AThe University of Maryland System · 1995
- Vibrio cholerae strain CVD103Hg.sup.r, method of making same, and vaccines derived therefrom21US 5,628,994 AUniversity of Maryland · 1997
- Deletion mutants of cholera vaccines expressing heterologous antigens16US 5,874,088 APresident and Fellows of Harvard College · 1999
- Cholera vaccine11US 4,328,209 ABoard of Regents, The University of Texas System · 1982
- Method of isolating restriction fragment deletions in vibrio cholerae and products thereof11US 4,935,364 ASwiss Serum and Vaccine Institute Berne · 1990